Drugs / Systemic therapy
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03904927 | Feb 2019 → Jan 2022 | esophageal squamous cell carcinoma | Fudan University | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Systemic therapy | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03904927 ↗ |
| Route | Intravenous | “docetaxel 75mg/m2, d1, intravenous infusion” NCT03904927 ↗ |